Market Cap (In PLN)
44.55 Million
Revenue (In PLN)
9.83 Million
Net Income (In PLN)
28.94 Million
Avg. Volume
3541.00
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.98-9.18
- PE
- -
- EPS
- -
- Beta Value
- 0.574
- ISIN
- PLPHRMN00011
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Konrad Palka
- Employee Count
- -
- Website
- https://www.pharmena.eu
- Ipo Date
- 2008-08-01
- Details
- Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
More Stocks
-
TRU
-
1643
-
688683
-
XPC
-
PYTCYPlaytech plc
PYTCY
-
WDO
-
9704
-
KDSX